The promise of chimeric antigen receptor T cells (CARTs) in leukaemia.

about

Mesenchymal Stem Cells in Myeloid Malignancies: A Focus on Immune Escaping and Therapeutic Implications.Building a Safer and Faster CAR: Seatbelts, Airbags, and CRISPR.Selection of a novel CD19 aptamer for targeted delivery of doxorubicin to lymphoma cells.

P2860

Q41695046-D4533336-1B16-4310-8C03-555317C761C1 Q47443955-7150AE0D-0CF2-466C-A9EC-96A05A70ACB4 Q55250617-B1E591FF-7813-4D59-A28E-57CB6D33DFBD

P2860

The promise of chimeric antigen receptor T cells (CARTs) in leukaemia.

Item

http://www.wikidata.org/entity/Q39039017

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

The promise of chimeric antigen receptor T cells (CARTs) in leukaemia.

@en

The promise of chimeric antigen receptor T cells

@nl

type

Item

label

The promise of chimeric antigen receptor T cells (CARTs) in leukaemia.

@en

The promise of chimeric antigen receptor T cells

@nl

prefLabel

The promise of chimeric antigen receptor T cells (CARTs) in leukaemia.

@en

The promise of chimeric antigen receptor T cells

@nl

P1476

The promise of chimeric antigen receptor T cells (CARTs) in leukaemia.

@en

P2093

David L Porter

http://www.w3.org/2001/XMLSchema#string

Noelle V Frey

http://www.w3.org/2001/XMLSchema#string

Robert J Orlowski

http://www.w3.org/2001/XMLSchema#string

P2860

Chimeric antigen receptor-modified T cells in chronic lymphoid leukemia

T cells with chimeric antigen receptors have potent antitumor effects and can establish memory in patients with advanced leukemia

Safety, activity, and immune correlates of anti-PD-1 antibody in cancer

Remote control of therapeutic T cells through a small molecule-gated chimeric receptor.

The interleukin-3 receptor alpha chain is a unique marker for human acute myelogenous leukemia stem cells

T cell exclusion, immune privilege, and the tumor microenvironment

CD19 antigen in leukemia and lymphoma diagnosis and immunotherapy

Chimeric antigen receptor T cells for sustained remissions in leukemia

Efficacy and toxicity management of 19-28z CAR T cell therapy in B cell acute lymphoblastic leukemia

Inducible apoptosis as a safety switch for adoptive cell therapy

P304

13-26

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/BJH.14475

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

177

http://www.w3.org/2001/XMLSchema#string

P577

2016-12-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27977050

http://www.w3.org/2001/XMLSchema#string

P921

leukemia

The promise of chimeric antigen receptor T cells (CARTs) in leukaemia.

about

P2860

P2860

The promise of chimeric antigen receptor T cells (CARTs) in leukaemia.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P921

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P921